Low Burden of Atrial Fibrillation After PFO Closure: Is There a Need to Worry?
作者信息
Poulin Marie-France, Kavinsky Clifford J
机构信息
Cardiovascular Institute, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
出版信息
J Soc Cardiovasc Angiogr Interv. 2024 Jun 4;3(7):102145. doi: 10.1016/j.jscai.2024.102145. eCollection 2024 Jul.
Abstract
摘要
相似文献
1
Low Burden of Atrial Fibrillation After PFO Closure: Is There a Need to Worry?
J Soc Cardiovasc Angiogr Interv. 2024 Jun 4;3(7):102145. doi: 10.1016/j.jscai.2024.102145. eCollection 2024 Jul.
2
Monitoring for atrial fibrillation prior to patent foramen ovale closure after cryptogenic stroke.
Int J Stroke. 2023 Apr;18(4):400-407. doi: 10.1177/17474930221124412. Epub 2022 Sep 19.
3
Embolic Stroke of Undetermined Source and Patent Foramen Ovale: Risk of Paradoxical Embolism Score Validation and Atrial Fibrillation Prediction.
Stroke. 2021 May;52(5):1643-1652. doi: 10.1161/STROKEAHA.120.032453. Epub 2021 Mar 31.
4
Long-term risk of atrial fibrillation or flutter after transcatheter patent foramen ovale closure: a nationwide Danish study.
Eur Heart J. 2023 Sep 21;44(36):3469-3477. doi: 10.1093/eurheartj/ehad305.
5
Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence.
BMJ Open. 2018 Jul 25;8(7):e023761. doi: 10.1136/bmjopen-2018-023761.
6
A matching-adjusted indirect comparison of results from REDUCE and RESPECT-two randomized trials on patent foramen ovale closure devices to prevent recurrent cryptogenic stroke.
J Med Econ. 2024 Jan-Dec;27(1):337-343. doi: 10.1080/13696998.2024.2320604. Epub 2024 Feb 29.
7
Atrial fibrillation screening on systematic ambulatory electrocardiogram monitoring after percutaneous patent foramen ovale closure: A prospective study.
Int J Cardiol Heart Vasc. 2021 Nov 20;37:100919. doi: 10.1016/j.ijcha.2021.100919. eCollection 2021 Dec.
8
Closure, Anticoagulation, or Antiplatelet Therapy for Cryptogenic Stroke With Patent Foramen Ovale: Systematic Review of Randomized Trials, Sequential Meta-Analysis, and New Insights From the CLOSE Study.
J Am Heart Assoc. 2018 Jun 17;7(12):e008356. doi: 10.1161/JAHA.117.008356.
9
Recurrent Stroke Reduction with Patent Foramen Ovale Closure versus Medical Therapy Based on Patent Foramen Ovale Characteristics: A Meta-Analysis of Randomized Controlled Trials.
Cardiology. 2019;144(1-2):40-49. doi: 10.1159/000500501. Epub 2019 Oct 1.
10
Patent foramen ovale closure in the management of cryptogenic stroke: a review of current literature and guideline statements.
Curr Med Res Opin. 2021 Mar;37(3):377-384. doi: 10.1080/03007995.2021.1876648. Epub 2021 Feb 8.
本文引用的文献
1
Approval, Evidence, and "Off-Label" Device Utilization: The Patent Foramen Ovale Closure Story.
Circ Cardiovasc Qual Outcomes. 2024 Jan;17(1):e010200. doi: 10.1161/CIRCOUTCOMES.123.010200. Epub 2024 Jan 8.
2
Incidence and time course of atrial fibrillation following patent foramen ovale closure.
Catheter Cardiovasc Interv. 2022 Aug;100(2):219-224. doi: 10.1002/ccd.30247. Epub 2022 Jun 1.
3
Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke.
JAMA. 2021 Dec 14;326(22):2277-2286. doi: 10.1001/jama.2021.20956.
4
Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial.
Lancet. 2021 Oct 23;398(10310):1507-1516. doi: 10.1016/S0140-6736(21)01698-6. Epub 2021 Aug 29.
5
Atrial Fibrillation Following Patent Foramen Ovale Closure: Systematic Review and Meta-Analysis of Observational Studies and Clinical Trials.
Stroke. 2021 May;52(5):1653-1661. doi: 10.1161/STROKEAHA.120.030293. Epub 2021 Feb 22.
6
Practice advisory update summary: Patent foramen ovale and secondary stroke prevention: Report of the Guideline Subcommittee of the American Academy of Neurology.
Neurology. 2020 May 19;94(20):876-885. doi: 10.1212/WNL.0000000000009443. Epub 2020 Apr 29.
7
European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism.
EuroIntervention. 2019 Jan 20;14(13):1389-1402. doi: 10.4244/EIJ-D-18-00622.
8
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
N Engl J Med. 2017 Sep 14;377(11):1011-1021. doi: 10.1056/NEJMoa1705915.
9
Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.
N Engl J Med. 2017 Sep 14;377(11):1022-1032. doi: 10.1056/NEJMoa1610057.
10
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
N Engl J Med. 2017 Sep 14;377(11):1033-1042. doi: 10.1056/NEJMoa1707404.
Zotero 插件